Pay in 4 interest-free payments of $5.57 Learn more
Ships within 48 hours · Estimated delivery Sep 17 - Sep 22
foxo4-dri senolytic peptide human trial 2024 — 10mg Bacteriostatic Water 0.9% 12mL mg:10 Energy & Metabolism
Bacteriostatic Water 0.9% 12mL | Defy Medical
From available case reports, compounding pharmacy data, and practitioner experience, the following have been observed: BPC-157 — Reported Side Effects Nausea and gastrointestinal discomfort (especially with oral administration) Dizziness or light-headedness Flushing or warmth at injection sites Headache Fatigue or somnolence in some users TB-500 — Reported Side Effects Injection site reactions (redness, mild pain, swelling) Transient fatigue or lethargy following administration Headache Possible flu-like symptoms in a minority of users Critical Risk Note: Because neither peptide has undergone full clinical trial evaluation in humans, the complete adverse event profile is unknown
Energy & Metabolism
mg:10
Opened at room temperature, 28 days from the first puncture
US$ 24.89
US$ 23.64
US$ 23.82